The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2025 | Multifactorial drivers of declining lung cancer mortality in America
Muhammad Islam, MBBS, MD, MsPH, FACP, University of Chicago, Chicago, IL, discusses the multifaceted decline in lung cancer mortality in the United States from 1994–2020. Male and female mortality has decreased over the years, with accelerated improvements after 2014 coinciding with drug approvals and reduced smoking prevalence. Additional contributors included cleaner air, healthcare reforms, and advances in precision medicine. Persistent socioeconomic disparities highlight the need for equitable access, prevention strategies, and fair distribution of personalized treatments. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
